Primary percutaneous transluminal angioplasty for early moyamoya disease

Journal of Neuroimaging

Volumn 17, Issue 1, 2007, Pages 48-53

  Rodriguez, Gustavo J ^a   Kirmani, Jawad F ^a   Ezzeddine, Mustapha A ^a   Qureshi, Adnan I ^a,b  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b NEUROLOGICAL INSTITUTE OF NEW JERSEY   (United States)

Author keywords

Angioplasty; Cerebral angiography; Ischemic stroke; Moyamoya disease

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN;

ADULT; ANAMNESIS; ARTICLE; BRAIN CORTEX; CASE REPORT; EMERGENCY WARD; FEMORAL ARTERY; FOLLOW UP; HEMIPARESIS; HUMAN; INTERNAL CAROTID ARTERY; MALE; MOYAMOYA DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT TRANSPORT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RESTENOSIS; RIGHT HANDEDNESS; STROKE UNIT; SUBARACHNOID HEMORRHAGE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; UNITED STATES;

ADULT; ANGIOPLASTY, BALLOON; CEREBRAL ANGIOGRAPHY; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; MALE; MOYAMOYA DISEASE; RECURRENCE;

EID: 33846080071     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/j.1552-6569.2006.00075.x     Document Type: Article

References (55)

1. Matsushima T, Fukui M, Fujii K, Fujiwara S, Nagata S, Kitamura K, Kuwabara Y. Two pediatric cases with occlusions of the ipsilateral internal carotid and posterior cerebral arteries associated with moyamoya vessels: 'Unilateral' moyamoya disease. Surg Neurol 1990;33:276-280.
2. Miyamoto S, Kikuchi H, Karasawa J, Nagata I, Ikota T, Takeuchi S. Study of the posterior circulation in moyamoya disease: clinical and neuroradiological evaluation. J Neurosurg 1984;61:1032-1037.
3. Yamada I, Himeno Y, Suzuki S, Matsushima Y. Posterior circulation in moyamoya disease: angiographic study. Radiology 1995;197:239-246.
4. Kuroda S, Ishikawa T, Houkin K, Iwasaki Y. Clinical significance of posterior cerebral artery stenosis/occlusion in moyamoya disease. No Shinkei Geka 2002;30:1295-1300.
5. Takeuchi K, Shimizu K. Hypogenesis of bilateral internal carotid arteries. No To Shinkei 1957;9:37-43.
6. Suzuki J. A study on disease showing singular cerebroangiographical findings which seem to be new collateral circulation. In: Proceedings of the 22nd Meeting of Japan Neurosurgical Society, 1963.
7. Suzuki J, Takaku A. Cerebrovascular 'moyamoya' disease: disease showing abnormal net-like vessels in base of brain. Arch Neurol 1969;20:288-299.
8. Pearson E, Lenn NJ, Cail WS. Moyamoya and other causes of stroke in patients with Down's syndrome. Pediatric Neurol 1985;1:174-179.
9. Cohen N, Beraut M, Simon J. Moyamoya and Fanconi's anemia. Pediatrics 1980;65:804-805.
10. Sunder TR. Moyamoya disease in a patient with type 1 glycogenesis. Arch Neurol 1981;38:251-253.
11. Servo A, Puranen M. Moyamoya syndrome as a complication of radiation therapy. J Neurosurg 1978;48:1026-1029.
12. Tomsick TA, Lukin RR, Chambers AA, Beaton C. Neurofibromatosis and intracranial arterial occlusive disease. Neuroradiology 1976;11:229-234.
13. Kazuhiro N, Kiyoyuki Y, Satoshi I, Tadao N. Multiple intracranial arterial stenoses around the circle of willis in association with Graves' disease: report of two cases. Neurosurgery 2003;53:1210-1215.
14. Paciaroni M, Micheli S, Caso V, Venti M, Alberti A, Milia P, Balucani C, Biagini S, Agnelli G. Angiographic findings of moyamoya vessels in a patient with rheumatoid arthritis. Cerebrovasc Dis 2005;20:415-416.
15. Garza-Mercado R. Pseudomoyamoya in sickle cell anemia. Surg Neurol 1982;18:425-431.
16. Yamashita M, Oka K, Tanaka K. Histopathology of the brain vascular network in moyamoya disease. Stroke 1983;14:50-58.
17. Kitahara T, Ariga N, Yamaura A, Makino H, Maki Y. Familial occurrence of moyamoya disease: report of three Japanese families. J Neurol Neurosurg Psychiatry 1979;42:208-214.
18. Fukuyama Y, Kanai N, Osawa M. Clinical genetic analysis on the moyamoya disease. In: The Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare Japan: Annual Report 1992. Tokyo, Japan: Ministry of Health and Welfare Japan; 1992:141-146.
19. Osawa M, Kanai N, Kawai M, Fukuyama Y. Clinical genetic study on the idiopathic occlusion of the circle of Willis. In: The Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare Japan: Annual Report 1992. Tokyo, Japan: Ministry of Health and Welfare Japan; 1992:147-152.
20. Yamauchi T, Houkin K, Tada M, Abe H. Familial occurrence of moyamoya disease. Clin Neurol Neurosurg 1997;99(suppl 2):S162-S167.
21. Ikeda H, Sasaki T, Yoshimoto T, Masashi F, Arinami T. Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p.26. Am J Hum Genet 1999;64:533-537.
22. Inoue TK, lkezaki K, Sasazuki T, Matsushima T, Fukui M. Linkage analysis of moyamoya disease on chromosome 6. J Child Neurol 2000;15:179-182.
23. Yamauchi T, Tada M, Houkin K, Tanaka T, Nakamura Y, Kuroda S, Abe H, Inoue T, Ikezaki K, Matsushima T, Fukui M. Linkage of Familial Moyamoya Disease (Spontaneous Occlusion of the Circle of Willis) to Chromosome 17q25. Stroke 2000;31:930-935.
24. Wakai K, Tamakoshi A, Ikezaki K, Fukui M, Kawamura T, Aoki R, Kojima M, Lin Y, Ohno Y. Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey. Clin Neurol Neurosurg 1997;99(suppl 2):S1-S5.
25. Yonekawa Y, Ogata N, Kaku Y, Taub E, Imhof HG. Moyamoya disease in Europe, past and present status. Clin Neurol Neurosurg 1997; 99(suppl 2):S58-S60.
26. Suzuki J, Kodama N. Moyamoya disease: a review. Stroke 1983;14:104-109.
27. Ikezaki K, Han DH, Kawano T, Kinuwaka N, Fukui M. A clinical comparison of definite moyamoya disease between South Korea and Japan. Stroke 1997;28:2513-2517.
28. Chiu D, Shedden P, Bratina P, Grotta JC. Clinical features of moyamoya disease in the United States. Stroke 1998;29:1347-1351.
29. Numaguchi Y, Gonzalez CF, Davis PC, Monajati A, Afshani E, Chang J, Sutton CL, Lee RR, Shibata DK. Moyamoya disease in the United States. Clin Neurol Neurosurg 1997;99(suppl 2):S26-S30.
30. Yilmaz Ey, Pritz MB, Bruno A, Lopez-Yunez A, Biller J. Moyamoya. Indiana University Medical Center Experience. Arch of Neurol 2001;58:1274-1278.
31. Cloft HJ, Kallmes DF, Snider R, Jensen ME. Idiopathic supraclinoid and internal carotid bifurcation steno-occlusive disease in young American adults. Neuroradiology 1999;41:772-776.
32. Hallemeier CL, Rich KM, Grubb RL, Chicoine MR, Moran CJ, Cross DT, Zipfel GJ, Dacey RG, Derdeyn CP. Clinical features and outcome in North American adults with moyamoya phenomenon. Stroke 2006;37:1490-1496.
33. Piao R, Oku N, Kitagawa K, Imaizumi M, Matsushita K, Yoshikawa T, Takasawa M, Osaki Y, Kimura Y, Kajimoto K, Hori M, Hatazawa J. Cerebral hemodynamics and metabolism in adult moyamoya disease: comparison of angiographic collateral circulation. Ann Nucl Med 2004;18:115-121.
34. Taki W, Yonekawa Y, Kobayashi A, Ishikawa M, Kikuchi H, Nishizawa S, Yonekura Y, Tanada S, Fukuyama H. Cerebral circulation and metabolism in adults' moyamoya disease: PET study. Acta Neurochir (Wien) 1989;100:150-154.
35. Aoki N, Mizutani H. Does moyamoya disease cause sub-arachnoid hemorrhage, Review of 54 cases with intracranial hemorrhage confirmed by computed tomography. J Neurosurg 1984;60:348-353.
36. Yuasa H, Tokito S, Izumi K, Hirabayashi K. Cerebral vascular moyamoya disease associated with an intracranial pseudoaneurysm. J Neurosurg 1982;56:131-134.
37. Morioka M, Hamada JI, Kawano T, Todaka T, Yano S, Kai Y, Ushio Y. Angiographic dilatation and branch extension of the anterior choroidal and posterior communicating arteries are predictors of hemorrhage in adult moyamoya patients. Stroke 2003;34:90-95.
38. Kuroda S, Ishikawa T, Houkin K, Nanba R, Hokari M, Iwasaki Y. Incidence and clinical features of disease progression in adult moyamoya disease. Stroke 2005;36:2148-2153.
39. Matsushima T, Take S, Fujii K, Hasuo K, Kuwabara Y, Kitomura K. A case of moyamoya disease with progressive involvement from unilateral to bilateral. Surg Neurol 1988;30:471-475.
40. Takahashi A, Fujiwara S, Suzuki J. Long-term follow-up angiography of moyamoya disease-cases followed from children to adolescence. No Shinkei Geka 1986;14:23-29.
41. Kelly ME, Bell-Stephens TE, Marks MP, Do HM, Steinberg GK. Progression of unilateral moyamoya disease: a clinical series. Cerebrovasc Dis 2006;22:109-115.
42. Horn P, Lanczik O, Vajkoczy P, Daffertshofer M, Bueltmann E, Werner A, Schmiedek P, Hennerici M. Hemodynamic reserve and high-intensity transient signals in moyamoya disease. Cerebrovasc Dis 2005;19:141-146.
43. Chiu D, Shedden P, Bratina P, Grotta JC. Clinical features of moyamoya disease in the United States. Stroke 1998;29:1347-1351.
44. Scott RM, Smith JL, Robertson RL, Madsen JR, Soriano SG, Rockoff MA. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. J Neurosurg 2004;100:S142-S149.
45. Yasargil MG. Experimental small vessel surgery in the dog including patching and grafting of cerebral vessels and formation of functional and extra-intracranial shunts. In: Donaghy RMP, Yasargil MG, eds. Microvascular Surgery. Stuttgart: George-Thieme, 1967:87-126.
46. Karasawa J, Touho H, Ohnishi H, Miyamoto S, Kikuchi H. Long-term follow-up study after extracranial-intracranial by after radiation for optic glioma. J Neurosurg 1993;79:32-35.
47. Matusushima Y, Fukai N, Tanaka K, Tsaruoka S, Inaba Y, Aoyagi M, Ohno K. A new surgical treatment of moyamoya disease in children: a preliminary report. Surg Neurol 1981;15:313-320.
48. Houkin K, Kuroda S, Nakayama N. Cerebral revascularization for moyamoya disease in children. Neurosurg Clin N Am 2001;12:575-584.
49. Yamada I, Matsushima Y, Suzuki S. Childhood moyamoya disease before and after encephalo-duro-arterio-synangiosis: an angiographic study. Neuroradiology 1992;34:318-322.
50. Ross IB, Shevell MI, Montes JL, Rosenblatt B, Watters GV, Farmer JP, O'Gorman AM. Encephaloduroarteriosynangiosis (EDAS) for the treatment of childhood moyamoya disease. Pediatr Neurol 1994;10:199-204.
51. Nishimoto T, Yuki K, Sasaki T, Murakami T, Kodama Y, Kurisu K. A ruptured middle cerebral artery aneurysm originating from the site of anastomosis 20 years after extracranial-intracranial bypass for moyamoya disease: case report. Surg Neurol 2005;64:261-265.
52. Voigtlander T, Rupprecht HJ, Britten M, Stahr P, Nowak B, Otto M, Kirkpatrick CJ, Brennecke R, Meyer J. In vitro examination of the coronary artery wall after balloon angioplasty using intracoronary ultrasound. Int J Cardiac Imaging 1998;14(1):65-70.
53. Surowiec SM, Sivamurthy N, Rhodes JM, Lee DE, Waldman DL, Green RM, Davies MG. Percutaneous therapy for renal artery fibromuscular dysplasia. Annals of Vascular Surgery 2003 Nov; 17(6):650-655.
54. Liebeskind DS, Sansing LH. Willisian collateralization. Neurology 2004;63:344.
55. Nakashima H, Meguro T, Kawada S, Hirotsune N, Ohmoto T. Long-term results of surgically treated moyamoya disease. Clin Neurol Neurosurg 1997;99(suppl 2):S156-S161.